Genprex, Inc. (NASDAQ:GNPX – Free Report) – HC Wainwright boosted their Q1 2024 earnings per share estimates for Genprex in a note issued to investors on Wednesday, April 3rd. HC Wainwright analyst Y. Chen now expects that the company will earn ($2.54) per share for the quarter, up from their previous estimate of ($3.37). HC […]
HC Wainwright assumed coverage on shares of Genprex (NASDAQ:GNPX – Free Report) in a report issued on Monday morning, Benzinga reports. The firm issued a buy rating and a $10.00 price objective on the stock. Genprex Stock Down 2.0 % NASDAQ GNPX opened at $3.00 on Monday. The stock’s 50-day simple moving average is $5.55 […]
Genprex, Inc. (NASDAQ:GNPX – Get Free Report) was the recipient of a significant drop in short interest in the month of September. As of September 30th, there was short interest totalling 1,650,000 shares, a drop of 6.8% from the September 15th total of 1,770,000 shares. Based on an average daily volume of 540,900 shares, the […]
Verus Capital Partners LLC decreased its stake in Genprex, Inc. (NASDAQ:GNPX – Free Report) by 37.3% in the first quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 55,500 shares of the company’s stock after selling 33,000 shares during the quarter. Verus Capital Partners LLC’s holdings in […]
Genprex, Inc. (NASDAQ:GNPX – Get Free Report)’s share price fell 8.9% on Wednesday . The stock traded as low as $0.79 and last traded at $0.79. 427,355 shares traded hands during mid-day trading, a decline of 15% from the average session volume of 501,663 shares. The stock had previously closed at $0.87. Genprex Trading Up […]